Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia

BACKGROUND: Mild therapeutic hypothermia (MTH) is believed to reduce the effectiveness of antiplatelet drugs. Effective dual-antiplatelet therapy after percutaneous coronary intervention (PCI) is mandatory to avoid acute stent thrombosis. The effectiveness of ticagrelor in MTH-treated out-of-hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomala, Marek T., Trąbka-Zawicki, Aleksander, Machnik, Andrzej, Nawrotek, Bartłomiej A., Zajdel, Wojciech, Stępień, Ewa Ł., Legutko, Jacek, Żmudka, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508063/
https://www.ncbi.nlm.nih.gov/pubmed/34165181
http://dx.doi.org/10.5603/CJ.a2021.0064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508063/
https://www.ncbi.nlm.nih.gov/pubmed/34165181
http://dx.doi.org/10.5603/CJ.a2021.0064

Ejemplares similares